Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
KOPRAN

Kopran Share Price

 

 

Kopran live price: ₹164.63. It opened at ₹157 vs previous close ₹157; intraday high/low: ₹167/₹155. The 50 & 200 DMA stand at ₹141.31/₹152.32.

Kopran Performance

  • Today's Low
  • ₹155
  • Today's High
  • ₹167
  • 52 Week Low
  • ₹107
  • 52 Week High
  • ₹213
  • Open Price₹157
  • Previous Close₹157
  • Volume393,759
  • 50 DMA₹141.31
  • 100 DMA₹141.51
  • 200 DMA₹152.32

Kopran Chart

Investment Returns

  • Over 1 Month + 38.58%
  • Over 3 Month + 30.7%
  • Over 6 Month -0.45%
  • Over 1 Year -14.65%

Smart Investing Starts Here Start SIP with Kopran for Steady Growth!

Invest Now

Kopran Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 48.1
  • PEG Ratio
  • -0.7
  • Market Cap Cr
  • 795
  • P/B Ratio
  • 1.6
  • Average True Range
  • 7.88
  • EPS
  • 3.43
  • Dividend Yield
  • 1.8
  • MACD Signal
  • 8.38
  • RSI
  • 66.65
  • MFI
  • 74

Kopran Financials

Kopran Technicals

EMA & SMA

Current Price
₹164.63
+ 7.5 (4.77%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹150.75
  • 50 Day
  • ₹141.31
  • 100 Day
  • ₹141.51
  • 200 Day
  • ₹152.32

Resistance and Support

162.11 Pivot Speed
  • R3 180.62
  • R2 173.61
  • R1 169.12
  • S1 157.62
  • S2 150.61
  • S3 146.12

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Kopran Ltd. is a fully integrated pharmaceutical company, engaged in the manufacturing and marketing of active pharmaceutical ingredients (APIs) and finished dosage forms. The company serves global markets with a focus on innovation, quality, and regulatory compliance.

Kopran has an operating revenue of Rs. 625.25 Cr. on a trailing 12-month basis. An annual revenue growth of 1% is not great, Pre-tax margin of 8% is okay, ROE of 7% is fair but needs improvement. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 22% and 9% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 19 which is a POOR score indicating inconsistency in earnings, a RS Rating of 73 which is FAIR indicating the recent price performance, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 61 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Kopran Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-01-22 Quarterly Results
2025-11-12 Quarterly Results
2025-07-29 Quarterly Results
2025-05-15 Audited Results & Final Dividend
2025-02-11 Quarterly Results
Date Purpose Remarks
2025-09-04 FINAL Rs.3.00 per share(30%)Final Dividend
View Kopran Dividend History Arrow

Kopran Shareholding Pattern

44.42%
0%
0.57%
0%
44.08%
10.93%

Kopran FAQs

Kopran share price is ₹164 As on 02 May, 2026 | 15:29

The Market Cap of Kopran is ₹794.9 Cr As on 02 May, 2026 | 15:29

The P/E ratio of Kopran is 48.1 As on 02 May, 2026 | 15:29

The PB ratio of Kopran is 1.6 As on 02 May, 2026 | 15:29

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23